GENE ONLINE|News &
Opinion
Blog

Deals
Trials & Approvals Hemophilia A
FDA Rejects BioMarin Pharmaceuticals’ Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
2020-08-20
Weekly Asia Highlights- Japan and India
2020-08-20
M&A Johnson & Johnson
Johnson & Johnson to Acquire Momenta Pharmaceutical Inc. for $6.5 Billion
2020-08-20
COVID-19
CureVac Shares Catapult 494% Following Successful IPO Debut
2020-08-18
M&A Multiple Sclerosis
Sanofi Advances in Multiple Sclerosis Market with Principia Acquisition Deal
2020-08-18
M&A Healthcare
Teladoc Health, Livongo Join Hands for Global Healthcare Delivery, Access, and Experience
2020-08-09
Deals Gene Editing
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
Deals
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
Funding
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
Deals
A New Paradigm in Biotech Innovation and Investment
2020-07-24Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
Licensing Crohn’s disease
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
Licensing IL-1R
Kymera Inks US$ 150M Deal with Sanofi for Potential Rheumatoid Arthritis and Eczema Treatments
2020-07-12
Funding Gene Therapy
Takeda, Carmine Ink $900 Million Pact for Non-Viral Gene Therapy
2020-07-05
Hemophilia B
CSL Behring to Tackle Hemophilia B Using UniQure’s Gene Therapy Program
2020-06-28
1 … 42 43 44 45 46 47
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top